Latest Beta amyloid Stories
Researchers have found that the brains of patients with early-onset Alzheimer's produce about 20 percent more of a protein fragment known as amyloid beta 42 than family members without the disease.
Mount Sinai researchers find reduction in brain plaques in mice after treatment with drugs currently prescribed for other indications. New York, NY (PRWEB) June
Alzheimer’s disease has been linked in many studies to amyloid plaque buildup in the brain, but new research is finding a common thread between amyloid burden and lower energy levels, or metabolism, of neurons in certain areas of the brain associated with Alzheimer’s disease—even for people with no sign of cognitive decline.
Scientists at the University of Liverpool and Callaghan Innovation in New Zealand have developed a new chemical approach to help harness the natural ability of complex sugars to treat Alzheimer's disease.
According to a group researchers, tests of the anti-cancer drug bexarotene failed to stop the formation of the amyloid brain plaques that are associated with Alzheimer’s disease, conflicting with the results of an identical 2012 study.
MetLife Foundation today announced the recipients of its 2013 Awards for Medical Research in Alzheimer’s Disease: Yueming Li, Ph.D., member and professor, Sloan-Kettering Institute and director
- A bereavement by loss of parents or children; the state of being orbate; orbation.